Generac executive sells 586 shares in plan trade

GENERAC HOLDINGS INC. executive Kyle Andrew Raabe, President, Home Power Gen., reported an options exercise and related sales on 2026-08-07 under a Rule 10b5-1(c) plan adopted on 05-05-2026.

Rhea-AI Filing Summary

GENERAC HOLDINGS INC. executive Kyle Andrew Raabe, President, Home Power Gen., reported an options exercise and related sales on 2026-08-07 under a Rule 10b5-1(c) plan adopted on 05-05-2026. He exercised options for 213 shares at a $102.415 exercise price and sold a total of 586 common shares at $213.35 per share in open-market or private transactions. Following the derivative transaction, he held 850 stock options with a graded vesting schedule and a stated expiration of 2030-03-01.

Insider Trade Summary 10b5-1

Exercise and sale activity reported; no spread calculated

Exercise and Sale 4 txns

Insider Raabe Kyle Andrew

Role President, Home Power Gen.

Sold 586 shs ($125K)

Approx. gross sale proceeds $125K

Approx. exercise cost $22K

Type	Security	Shares	Price	Value
Exercise	Stock Option (Right to Buy) F3	213	$0.00	$0.00
Sale	Common Stock F1, F2	373	$213.35	$80K
Exercise	Common Stock F1	213	$102.415	$22K
Sale	Common Stock F1, F2	213	$213.35	$45K

Holdings After Transaction: Stock Option (Right to Buy) — 850 contracts (Direct); Common Stock — 10,746 shares (Direct)

Footnotes (3)

1. F1. Adoption date of referenced 10b5-1(c) plan is: 05-05-2026
2. F2. Multiple lots for the same price for this order have been combined.
3. F3. Grant has a graded vesting schedule. Date Exercisable will vary for each vesting tranche.

Key Figures

Shares sold: 586 shares Options exercised: 213 shares Exercise price: $102.415 per share +4 more

7 metrics

Shares sold 586 shares Total common shares sold on 2026-08-07

Options exercised 213 shares Underlying common shares acquired via option exercise

Exercise price $102.415 per share Stock option exercise price for 213 shares

Sale price $213.35 per share Per-share price for reported common stock sales

Options remaining 850 options Stock options held after derivative transaction

Option expiration 2030-03-01 Expiration date of exercised option grant

10b5-1 plan adoption 05-05-2026 Adoption date of referenced Rule 10b5-1(c) plan

Key Terms

Rule 10b5-1(c), Stock Option (Right to Buy), graded vesting schedule, open market or private transaction

4 terms

Rule 10b5-1(c) regulatory

"Adoption date of referenced 10b5-1(c) plan is: 05-05-2026"

Rule 10b5-1(c) is an SEC guideline that lets company insiders set up a written, pre-planned schedule to buy or sell their company stock when they are not in possession of material, nonpublic information. For investors, it matters because such plans can reduce the appearance of insider trading by separating decisions from inside knowledge—like putting your trades on autopilot—while also requiring scrutiny since pre-planned trades can still affect market confidence and share value.

Stock Option (Right to Buy) financial

"security_title: Stock Option (Right to Buy)"

graded vesting schedule financial

"Grant has a graded vesting schedule. Date Exercisable will vary"

open market or private transaction financial

"Sale in open market or private transaction"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did GNRC executive Kyle Andrew Raabe report in this Form 4?

Kyle Andrew Raabe reported an options exercise of 213 shares at $102.415 and sales of 586 common shares at $213.35 per share, all dated 2026-08-07.

How many Generac (GNRC) shares did Kyle Raabe sell and at what price?

Kyle Raabe sold a total of 586 common shares of Generac at a $213.35 per-share price in open-market or private transactions on 2026-08-07.

What options did the GNRC executive exercise in this transaction?

He exercised stock options for 213 shares of Generac common stock at an exercise price of $102.415 per share, as part of a derivative transaction reported on 2026-08-07.

Was the GNRC insider trading under a Rule 10b5-1 plan?

Yes. The transactions were executed under a Rule 10b5-1(c) trading plan, with an adoption date disclosed as 05-05-2026, indicating a pre-arranged trading program.

How many stock options does Kyle Raabe hold after the GNRC transaction?

After the reported derivative transaction, Kyle Raabe held 850 stock options in Generac, subject to a graded vesting schedule and an expiration date of 2030-03-01.

What is the vesting structure of the GNRC options in this filing?

The options subject to the derivative transaction have a graded vesting schedule, meaning different tranches vest over time; the note states the date exercisable varies for each vesting tranche.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/10/2026 - 05:04 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Raabe Kyle Andrew

(Last) (First) (Middle)

S45 W29290 HWY.59

C/O GENERAC HOLDINGS INC.

(Street)

WAUKESHA WISCONSIN 53189

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
GENERAC HOLDINGS INC. [ GNRC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President, Home Power Gen.

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/07/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/07/2026		S(1)(2)		373	D	$213.35	10,746	D
Common Stock	08/07/2026		M(1)		213	A	$102.415	10,959	D
Common Stock	08/07/2026		S(1)(2)		213	D	$213.35	10,746	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$102.415	08/07/2026		M			213	(3)	03/01/2030	Common Stock	213	$0	850	D

Explanation of Responses:

1. Adoption date of referenced 10b5-1(c) plan is: 05-05-2026

2. Multiple lots for the same price for this order have been combined.

3. Grant has a graded vesting schedule. Date Exercisable will vary for each vesting tranche.

	/s/ Raj Kanuru, Attorney in Fact	08/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)